Increased levels of PCSK9 levels in patients on statin treatment could indicate a possible implication of PCSK9 in the lipoprotein TG contents by lipoprotein lipase regulation in CKD patients and an effect on high cardiovascular burden in this patient population. Here, PCSK9 is linked to chronic kidney disease.